Can slow intestinal transit increase enterohepatic reabsorption and reduce fecal elimination of bile-excreted compounds?

Slow intestinal transit is meaningfully linked to reduced fecal loss of endogenous bile acids, consistent with greater enterohepatic recycling. This is most directly relevant to bile acids; the magnitude and clinical relevance for drugs, metabolites, or toxicants excreted in bile are compound-specific.

Clinical and physiological evidence

• In constipation-predominant functional bowel disorders and slow-transit constipation, slower colonic transit has been associated with lower 48-hour total fecal bile-acid excretion, including lower deoxycholic acid and lower primary and secondary bile acids.
• The relationship is directionally supported by transit manipulation: shortening transit with senna increased fecal primary and secondary bile acids. Thus, faster passage appears to leave less opportunity for recycling and increases fecal loss.
• Approximately 95% of bile acids are normally reabsorbed. Net fecal elimination is therefore the relatively small fraction that escapes intestinal reclamation; increased reabsorption necessarily reduces fecal loss.

Mechanistic explanation

• Most bile-acid uptake occurs in the terminal ileum, but bile acids that reach the colon can also be passively absorbed.
• Longer colonic residence provides more time for microbial transformation and passive colonic absorption of bile acids, plausibly explaining lower fecal excretion during slow transit.
• For other biliary-excreted compounds, enterohepatic cycling depends on molecular properties, biliary secretion, intestinal/hepatic transport, deconjugation, and microbial metabolism. The bile-acid mechanism cannot be assumed to apply quantitatively to every compound.

Clinical implications

• In a 77-year-old man with constipation or otherwise slow transit, reduced fecal elimination of bile acids is biologically plausible and supported by human evidence.
• Whether slow transit materially changes exposure to a particular medication or toxin requires compound-specific pharmacokinetic evidence; reduced fecal recovery can also reflect altered secretion, synthesis, stool output, or degradation.

Bottom line

• Slow transit can increase enterohepatic reabsorption and reduce fecal elimination, with the strongest evidence for endogenous bile acids; extrapolation to other biliary-excreted compounds should be individualized.